Trump Demands Lower Prescription Drug Prices in Letters to Pharmaceutical Companies
4 Articles
4 Articles
Trump Issues Drug Price Ultimatum to Big Pharma - American Faith
President Donald Trump warned 17 major pharmaceutical companies on Thursday that they must lower prescription drug prices or face undisclosed punitive measures. The ultimatum follows his recent executive order aimed at bringing U.S. drug costs in line with prices in other developed nations. In a series of letters posted on his official Truth Social platform, Trump gave the companies a 60-day window to work with his administration on pricing refo…
Video/Pic: Trump demands drug companies lower prices
President Donald Trump sent 17 pharmaceutical companies letters on Thursday and demanded that the companies lower prices for Americans. The president warned that the “unacceptable burden” of prescription drug prices will “end” with his administration. During a press briefing on Thursday, White House Press Secretary Karoline Leavitt said, “The president signed an executive order earlier this year to solve the problem of exorbitant pharmaceutical …
The 17 pharmaceutical companies that Trump has sent letters to, according to his TrueSocial profile, were AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Novartis, Gilead, EMD Serono, Pfizer, Novo Nordisk, AstraZeneca, Amgen, Genentech, J&J, GSK, Merck, Regeneron, Sanofi and Eli Lilly.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium